Supplementation of infant formulas with recombinant human lactoferrin and/or galactooligosaccharides increases iron bioaccessibility as measured by ferritin formed in Caco-2 cell model
This is a novel study of nutritional functionality of human lactoferrin and galactooligosaccharides in infant formula. Recombinant human lactoferrin (hLf) determines iron solubility as well as bioaccessibility in infant formula High percentage of hLf remains stable after in vitro digestion (IVD) and modulates iron bioaccessibility Released peptides after IVD of hLf increase Fe solubility and intestinal cell uptake